Uncategorized
XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise
XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise
Plus, news about PCI Pharma:
🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s manufacturing facility … Read More